Texas Instruments Incorporated (TXN) is down 3.1% today. Here is some analysis on what might have caused this price movement.
Analysis: The day’s drop looks less tied to a single new company headline and more consistent with a valuation-driven pullback after a strong run, with investors focusing on near-term margin sensitivity from TI’s manufacturing ramp. Recent insider selling disclosures may also have added to caution. This could also be because the broader semiconductor group has been choppy in recent sessions, amplifying moves in higher-multiple names.
Details:
Sources:
Texas Instruments (TI.com newsroom), U.S. SEC (EDGAR), Investing.com, Barchart
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$TXN Insider Trading Activity
$TXN insiders have traded $TXN stock on the open market 40 times in the past 6 months. Of those trades, 0 have been purchases and 40 have been sales.
Here’s a breakdown of recent trading of $TXN stock by insiders over the last 6 months:
- RAFAEL R LIZARDI (Sr. Vice President & CFO) has made 0 purchases and 9 sales selling 159,903 shares for an estimated $41,706,702.
- MOHAMMAD YUNUS (Sr. Vice President) has made 0 purchases and 3 sales selling 51,098 shares for an estimated $13,818,950.
- MARK GARY (Sr. Vice President) has made 0 purchases and 3 sales selling 36,858 shares for an estimated $9,058,875.
- MARK T. ROBERTS (Sr. Vice President) has made 0 purchases and 3 sales selling 32,541 shares for an estimated $8,858,537.
- HAVIV ILAN (Chairman, President & CEO) sold 20,000 shares for an estimated $5,606,450
- SHANON J LEONARD (Sr. Vice President) sold 18,189 shares for an estimated $5,055,707
- AMICHAI RON (Sr. Vice President) sold 18,365 shares for an estimated $5,003,213
- MARK A BLINN has made 0 purchases and 4 sales selling 18,144 shares for an estimated $4,859,335.
- AHMAD BAHAI (Sr. Vice President) has made 0 purchases and 4 sales selling 18,160 shares for an estimated $4,698,498.
- JULIE C. KNECHT (VP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 9,956 shares for an estimated $2,774,786.
- CARRIE SMITH COX has made 0 purchases and 2 sales selling 8,838 shares for an estimated $2,708,028.
- KATHARINE KANE (SVP and General Counsel) has made 0 purchases and 2 sales selling 6,125 shares for an estimated $1,656,283.
- RONALD KIRK sold 9,990 shares for an estimated $1,621,687
- HAGOP H KOZANIAN (Sr. Vice President) sold 6,843 shares for an estimated $1,546,167
- PAMELA H PATSLEY sold 4,306 shares for an estimated $1,188,918
- TODD M BLUEDORN sold 4,306 shares for an estimated $1,180,929
- CHRISTINE WITZSCHE (Sr. Vice President) sold 3,625 shares for an estimated $998,770
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$TXN Hedge Fund Activity
We have seen 1,184 institutional investors add shares of $TXN stock to their portfolio, and 1,176 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 4,138,702 shares (-26.2%) from their portfolio in Q1 2026, for an estimated $788,257,182
- BANK OF NEW YORK MELLON CORP added 4,129,601 shares (+33.6%) to their portfolio in Q1 2026, for an estimated $786,523,806
- FRANKLIN RESOURCES INC removed 3,683,645 shares (-40.2%) from their portfolio in Q1 2026, for an estimated $701,587,026
- D. E. SHAW & CO., INC. added 3,615,526 shares (+93.2%) to their portfolio in Q4 2025, for an estimated $627,257,605
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,936,352 shares (-24.8%) from their portfolio in Q1 2026, for an estimated $559,257,601
- GOLDMAN SACHS GROUP INC added 2,864,541 shares (+41.7%) to their portfolio in Q1 2026, for an estimated $545,580,478
- SLATE PATH CAPITAL LP added 2,670,225 shares (+inf%) to their portfolio in Q1 2026, for an estimated $508,571,053
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$TXN Congressional Stock Trading
Members of Congress have traded $TXN stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $TXN stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $1,000,000 on 03/18.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/18.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 11/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$TXN Analyst Ratings
Wall Street analysts have issued reports on $TXN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Rosenblatt issued a "Buy" rating on 01/28/2026
- Mizuho issued a "Underperform" rating on 01/28/2026
- Benchmark issued a "Buy" rating on 01/28/2026
- JP Morgan issued a "Overweight" rating on 01/28/2026
To track analyst ratings and price targets for $TXN, check out Quiver Quantitative's $TXN forecast page.
$TXN Price Targets
Multiple analysts have issued price targets for $TXN recently. We have seen 20 analysts offer price targets for $TXN in the last 6 months, with a median target of $292.5.
Here are some recent targets:
- Vijay Rakesh from Mizuho set a target price of $300.0 on 05/19/2026
- Matthew Prisco from Cantor Fitzgerald set a target price of $300.0 on 05/13/2026
- Tore Svanberg from Stifel set a target price of $290.0 on 04/23/2026
- Kevin Cassidy from Rosenblatt set a target price of $330.0 on 04/23/2026
- Tristan Gerra from Baird set a target price of $300.0 on 04/23/2026
- James Schneider from Goldman Sachs set a target price of $200.0 on 04/23/2026
- John Vinh from Keybanc set a target price of $325.0 on 04/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.